Showing results (1391-1400 of 1,615) with videos related to

Sort By:
Pageof 162
Tumori|January 7, 2023
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patientsBeatrice Borelli, Stefania Crucitta, Alessandra Boccaccino, et al.
ESMO Open|December 7, 2017
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical studyChiara Cremolini, Filippo Pietrantonio, Gianluca Tomasello, et al.
The Oncologist|April 21, 2017
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV StudyChiara Alessandra Cella, Giovanni Di Minno, Chiara Carlomagno, et al.
Gigascience|April 17, 2018
The genome sequence and transcriptome of Potentilla micrantha and their comparison to Fragaria vesca (the woodland strawberry)Matteo Buti, Marco Moretto, Elena Barghini, et al.
ESMO Open|June 25, 2019
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectableElena Ongaro, Chiara Cremolini, Daniele Rossini, et al.
European Urology Open Science|September 24, 2024
A Propensity Score-matched Comparison of Micro-ultrasound-guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate CancerAndrea Piccolini, Pier Paolo Avolio, Cesare Saitta, et al.
Vaccines|May 27, 2023
Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of PadovaPaola Mason, Rosario Rizzuto, Luca Iannelli, et al.
Scientific Reports|January 18, 2020
PulmonDB: a curated lung disease gene expression databaseAna B Villaseñor-Altamirano, Marco Moretto, Mariel Maldonado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2015
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosisC Cremolini, M Di Bartolomeo, A Amatu, et al.
Clinical Colorectal Cancer|August 8, 2021
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer PatientsRoberto Moretto, Daniele Rossini, Iolanda Capone, et al.
Pageof 162